@incollection{,
	
					
					
					BAE7EBEE24DE9D7C3CB56F1BA5692659
				,
	author={{Ahmed ShakerAli} and {Samar Faisal AMiski} and {King Abdulaziz University}},
	journal={{Global Journal of Medical Research}},
	journal={{GJMR}}2249-46180975-588810.34257/GJMR,
	address={Cambridge, United States},
	publisher={Global Journals Organisation}2073539
}

@book{b0,
	
	
		,
	title={{Drug Use Disorders and Addiction, in Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 13e}}
		,
	author={{
			CPO'brien
		}}
		,
	editor={L.L. Brunton, R. Hilal-Dandan, and B.C. Knollmann}
		
			,
	year={2017}
			,
	publisher={McGraw-Hill Education}
			,
	address={New York, NY}
		
	

}

@incollection{b1,
	
	
		,
	title={{Classic hallucinogens in the treatment of addictions}}
		,
	author={{
			MPBogenschutz
		} and {
			MWJohnson
		}}
		
	
	
		,
	journal={{Progress in Neuro-Psychopharmacology and Biological Psychiatry}}
		
			64
			
			,
	year={2016}
		
	

}

@incollection{b2,
	
	
		,
	title={{}}
		,
	author={{
			GFKoob
		}}
	
	
		,
	journal={{Pathophysiology of Addiction}}
		
			1
			
			,
	year={2015}
		
	
	,
	note={Psychiatry}

}

@incollection{b3,
	
	
		,
	title={{Drugs of Abuse}}
		,
	author={{
			CLüscher
		}}
	
	
		,
	booktitle={{Basic &amp}}
				
	

}

@incollection{b4,
	
	
		,
	title={{}}
	
	
		,
	journal={{Clinical Pharmacology}}
		,
	editor={B.G. Katzung}
		
			,
	year={2017}
			,
	publisher={McGraw-Hill Education}
		
	

}

@incollection{b5,
	
	
		,
	title={{Psychedelic Drugs in Biomedicine}}
		,
	author={{
			EJKyzar
		}}
	
	
		,
	journal={{Trends Pharmacol Sci}}
		
			38
			11
			
			,
	year={2017}
		
	

}

@book{b6,
	
	
		,
	title={{Chapter 14-Natural Product (Fungal and Herbal) Novel Psychoactive Substances}}
		,
	author={{
			SGibbons
		} and {
			WArunotayanun
		}}
		
		,
	editor={Novel Psychoactive Substances, P.I. Dargan and D.M. Wood}
		
			,
	year={2013}
			,
	publisher={Academic Press}
			
			,
	address={Boston}
		
	

}

@incollection{b7,
	
	
		,
	title={{Research on psychedelic substances}}
		,
	author={{
			SDBrandt
		} and {
			TPassie
		}}
		
	
	
		,
	journal={{Drug Test Anal}}
		
			4
			
			,
	year={2012}
		
	

}

@incollection{b8,
	
	
		,
	title={{Psychedelic medicine: a reemerging therapeutic paradigm}}
		,
	author={{
			KWTupper
		}}
	
	
		,
	journal={{CMAJ: Canadian Medical Association journal = journal de l'Association medicale canadienne}}
		
			187
			14
			
			,
	year={2015}
		
	

}

@incollection{b9,
	
	
		,
	title={{Effects of ayahuasca on the development of ethanol-induced behavioral sensitization and on a post-sensitization treatment in mice}}
		,
	author={{
			AJOliveira-Lima
		}}
	
	
		,
	journal={{Physiol Behav}}
		
			142
			
			,
	year={2015}
		
	

}

@incollection{b10,
	
	
		,
	title={{Harmane Induces Anxiolysis and Antidepressant-Like Effects in Rats}}
		,
	author={{
			FAricioglu
		}}
	
	
		,
	journal={{Annals of the New York Academy of Sciences}}
		
			1009
			1
			
			,
	year={2003}
		
	

}

@incollection{b11,
	
	
		,
	title={{Behavioural and neurotoxic effects of ayahuasca infusion (Banisteriopsis caapi and Psychotria viridis) in female Wistar rat}}
		,
	author={{
			APic-Taylor
		}}
	
	
		,
	journal={{Behavioural Processes}}
		
			118
			
			,
	year={2015}
		
	

}

@incollection{b12,
	
	
		,
	title={{Ayahuasca: Pharmacology, neuroscience and therapeutic potential}}
		,
	author={{
			EDominguez-Clave
		}}
	
	
		,
	journal={{Brain Res Bull}}
		
			126
			
			,
	year={2016}
		
	
	,
	note={Pt 1)}

}

@incollection{b13,
	
	
		,
	title={{The Therapeutic Potentials of Ayahuasca: Possible Effects against Various Diseases of Civilization}}
		,
	author={{
			EFrecska
		} and {
			PBokor
		} and {
			MWinkelman
		}}
		
		
	
	
		,
	journal={{Front Pharmacol}}
		
			7
			35
			,
	year={2016}
		
	

}

@incollection{b14,
	
	
		,
	title={{Ibogaine and addiction in the animal model, a systematic review and metaanalysis}}
		,
	author={{
			MBelgers
		}}
	
	
		,
	journal={{Transl Psychiatry}}
		
			6
			5
			e826
			,
	year={2016}
		
	

}

@incollection{b15,
	
	
		,
	title={{Toxicokinetics of ibogaine and noribogaine in a patient with prolonged multiple cardiac arrhythmias after ingestion of internet purchased ibogaine}}
		,
	author={{
			MHenstra
		}}
	
	
		,
	journal={{Clin Toxicol}}
		
			55
			6
			
			,
	year={2017}
		
	

}

@incollection{b16,
	
	
		,
	title={{Ibogaine Detoxification Transitions Opioid and Cocaine Abusers between Dependence and Abstinence: Clinical Observations and Treatment Outcomes}}
		,
	author={{
			DCMash
		}}
	
	
		,
	journal={{Front Pharmacol}}
		
			9
			529
			,
	year={2018}
		
	

}

@incollection{b17,
	
	
		,
	title={{Cytochrome P450 and Omethyltransferase catalyze the final steps in the biosynthesis of the anti-addictive alkaloid ibogaine from Tabernanthe iboga}}
		,
	author={{
			SCFarrow
		}}
	
	
		,
	journal={{J Biol Chem}}
		
			293
			36
			
			,
	year={2018}
		
	

}

@incollection{b18,
	
	
		,
	title={{Anti-addiction Drug Ibogaine Prolongs the Action Potential in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes}}
		,
	author={{
			LRubi
		}}
	
	
		,
	journal={{Cardiovascular Toxicology}}
		
			17
			2
			
			,
	year={2017}
		
	

}

@book{b19,
	
	
		,
	title={{Pharmacology and antiaddiction effects of the novel ? opioid receptor agonist Mesyl Sal B, a potent and long-acting analogue of salvinorin A. British journal of pharmacology}}
		,
	author={{
			BSimonson
		}}
		
			,
	year={2015}
			172
			
		
	

}

@book{b20,
	
	
		,
	title={{Kappa opioid receptor signaling in the brain: Circuitry and implications for treatment. Progress in neuro-psychopharmacology & biological psychiatry}}
		,
	author={{
			NACrowley
		} and {
			TLKash
		}}
		
		
			,
	year={2015}
			62
			
		
	

}

@book{b21,
	
	
		,
	title={{Neuropharmacological Potential and Delivery Prospects of Thymoquinone for Neurological Disorders. Oxidative medicine and cellular longevity}}
		,
	author={{
			MJakaria
		}}
		
			,
	year={2018. 2018}
		
	

}

@book{b22,
	
	
		,
	title={{Potential therapeutic effects of thymoquinone on treatment of amphetamine abuse}}
		,
	author={{
			NMd Fauzi
		}}
		
			,
	year={2018. 187}
			8
		
	

}

@incollection{b23,
	
	
		,
	title={{Human hallucinogen research: guidelines for safety}}
		,
	author={{
			MJohnson
		} and {
			WRichards
		} and {
			RGriffiths
		}}
		
		
	
	
		,
	journal={{Journal of psychopharmacology}}
		
			22
			6
			
			,
	year={2008}
		
	

}

@incollection{b24,
	
	
		,
	title={{The behavioral pharmacology of hallucinogens}}
		,
	author={{
			WEFantegrossi
		} and {
			KSMurnane
		} and {
			CJReissig
		}}
		
		
	
	
		,
	journal={{Biochemical pharmacology}}
		
			75
			1
			
			,
	year={2008}
		
	

}